Randomized discontinuation trials: Utility and efficiency
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
The randomized discontinuation trial (RDT) is a two-phase trial. In phase I all patients are openly treated with the medication being evaluated. In phase II, those who have responded are randomly assigned to continue the same treatment or switch to placebo. Usually, non-compliers and "adverse reactors" identified in phase I are excluded from phase II. To investigate the value of this design, we reviewed the advantages and limitations of discontinuation studies, and compared the RDT design to the classic randomized clinical trial design in terms of clinical utility and efficiency (sample size). A computer model was used to study the efficiency of the two designs under a broad range of assumptions. The RDT design is particularly useful in studying the effect of long-term, non-curative therapies, especially when the clinically important effect is relatively small, and the use of placebo should be minimized for ethical or feasibility reasons. However, its use is limited if the objective of an investigation is to estimate the magnitude of absolute treatment effects and toxic effects in the source population, or to evaluate a potentially curative treatment. Our results indicate that selecting responders prior to randomization has a very strong effect on the relative efficiency of the trial. Further improvement may be achieved by excluding non-compliers and adverse reactors. Under the assumptions tested in our model, the sample size required in phase II of an RDT was only 20-50% of…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,253
Fundamentals of Clinical Trials
Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015) · doi:10.1007/978-3-319-18539-2 · Cited by 2,237
Statistical Methods in Medical Research.
Wickham, C. A. C., Armitage, P., & Berry, G. (1988) · Journal of the Royal Statistical Society. Series A (Statistics in Society) · doi:10.2307/2982765 · Cited by 1,397
(1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240303 · Cited by 677
Patient Compliance in Medical Practice and Clinical Trials
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-7-582_3 · Cited by 464
A CLICKING HIP IN A NEWBORN BABY SHOULD NEVER BE IGNORED
Cunningham, K. T., Beningfield, S., Moulton, A., & Maddock, C. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92180-9 · Cited by 387
Fundamentals of Clinical Trials
Rhoads, G. G. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380080101043 · Cited by 342
Stones in the kidney and ureter.
Hellström, J. (1948) · PubMed · Cited by 323
Long-term Diazepam Therapy and Clinical Outcome
Rickels, K. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03340060045024 · Cited by 276
Long-term Diazepam Therapy and Clinical Outcome
Rickels, K. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.250.6.767 · Cited by 276
Research works printed but not linked: 1
- Snider, 1984, Sixmonth isoniazid-rifampin therapy for pulmonary tuberculosis, Am Rev Respir Dis, 129, 573
Cited by
Ratain, M. J., Eisen, T., Stadler, W. M., Flaherty, K. T., Kaye, S. B., Rosner, G. L., Gore, M., Desai, A. A., Patnaik, A., Xiong, H. Q., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6723 · Cited by 1,032
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
Hidalgo, M., & Eckhardt, S. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.178 · Cited by 798
Rini, B. I., & Small, E. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.186 · Cited by 408
Clinical Trial Designs for Cytostatic Agents: Are New Approaches Needed?
Korn, E. L., Arbuck, S. G., Pluda, J. M., Simon, R., Kaplan, R. S., & Christian, M. C. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.265 · Cited by 331
MacLehose, Reeves, Harvey, Sheldon, Russell, & Black (2000) · Health Technology Assessment · doi:10.3310/hta4340 · Cited by 311
Metadata
- Authors
- Kopec, J. A., Abrahamowicz, M., & Esdaile, J. M.
- Affiliations
- Montreal General Hospital (CA)
- Venue
- Journal of Clinical Epidemiology
- Publisher
- Elsevier BV
- Published
- 1993-09
- Volume
- 46
- Issue
- 9
- Pages
- 959-971
- ISSN
- 0895-4356 (ISSN-L)
- OpenAlex
- W2073680312
- Cited by
- 134
- References
- 60
- Citations by year
- 2026: 1 · 2025: 3 · 2023: 2 · 2022: 2 · 2020: 6 · 2019: 2 · 2018: 7 · 2017: 5 · 2016: 4 · 2015: 3 · 2014: 8 · 2013: 4 · 2012: 5
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Clinical Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI 07306, T32AI007306)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P60AR036308, AR-36308, AR-07530, T32AR007530)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Decision Sciences › Management Science and Operations Research › Optimal Experimental Design Methods
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Keywords
- relative efficiency, sample size, non-compliance, computer simulation, treatment effect estimation
- MeSH terms
- Computer Simulation, Humans, Models, Theoretical, Placebos, Research Design, Sampling Studies, Randomized Controlled Trials as Topic, Treatment Refusal, Efficiency, Organizational, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomized discontinuation trials: Utility and efficiency. https://app.cochat.ai/papers/10.1016/0895-4356(93)90163-u
- The paper
- Kopec, J. A., Abrahamowicz, M., & Esdaile, J. M. (1993). Randomized discontinuation trials: Utility and efficiency. Journal of Clinical Epidemiology. https://doi.org/10.1016/0895-4356(93)90163-u
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.